BMAL1 and Cognitive impairment: Consistent with the administration route of intraperitoneal injection, direct application of CCPA in the hippocampus (by a mini‐osmotic pump) ameliorated, whereas DPCPX treatment aggravated, the cognitive impairments in Bmal1‐iKO mice (Figure S7G–J, Supporting Information).